Field Medical Affairs Manager

Reporting to the Oncology associate medical director, the Field Medical Affairs Manager is responsible for supporting the development and execution of the Country Medical Affairs strategy and also works with other functions to support the development, commercialization and life cycle management of in-market and future Jazz Pharma products. The Jazz mission is to bring meaningful medicines to patients with high unmet medical need. Jazz plans to establish itself as a key partner to Oncologists, with a focus on BTC, GEA and Breast cancer, and their patients in the UK and Ireland. With the aspiration of building our knowledge and support to this area, Jazz will engage in clinical trials, data generation, work closely with KEEs and PAGs, supporting education, scientific exchange and developing a deep understanding of the pathway challenges within the NHS. The role has responsibility for ensuring all activities are executed in accordance with regulatory and legal frameworks including but not limited to ABPI/IPHA codes, MHRA, EFPIA, GCP and IFPMA regulations as well as Jazz Pharmaceuticals Policies and Healthcare compliance procedures. Support of UK/Ire Medical Affairs Team Priority Responsiblities Works closely with the Associate Medical Director and the Medical Director to implement and execute the UK/Ire Solid Tumour medical affairs plan, within the overall framework of the affiliate medical plan The majority of work involved in the Field Medical Affairs Manager role pertains to customer-facing field-based activities including proactive and reactive engagement with KEEs, to gather insights and build knowledge to feed into medical strategy. The role will also entail engaging and supporting clinical trial investigators throughout the clinical development program, from site enquires, through to feasibility, SIV, recruitment queries and investigator meetings.

• Supports the creation of training materials and other scientific materials, and provides medical/scientific education and internal medical training, as agreed by AMD/MD.
• Acts as medical reviewer and approver of materials for compliance with the ABPI/IPHA Code(s) of Practice.
• Engages with Medical affairs, Affiliate-wide and enterprise projects as required.
External Relationships
• According to KEE engagement plan, develops & maintains a high level of knowledge of Therapy Area and related scientific literature in order to engage in credible peer-to-peer discussions with KEEs in the field.
• Acts as first point of contact for KEEs and research collaborators in the UK and Ireland.
• Answer questions from HCPs, communicating salient facts in a clear, factual and non-promotional manner.
• Develops meaningful collaborative relationships with KEEs thereby supporting the development of Jazz positioning as the scientific authority in Solid Tumour Oncology, specifically HER2 solid oncology.
• Develops KOL advocacy through the provision of relevant scientific and clinical information.
• Develops speakers through one-on-one training on approved medical slide decks.
• Spending time with HCPs, listening to and observing the challenges faced in the NHS to understand their needs and create actionable medical insights.
• Delivers proactive and reactive engagement with KEEs gather insights to feed into medical strategy and cross-functional knowledge of the external environment.
• Provides high quality compliant medical engagement and interactions at appropriate scientific congresses and build knowledge to stay abreast of developments.
Strategic and Tactical Planning Works closely with the AMD to implement the UK medical affairs tactics aligned to agreed strategic imperatives and defined country needs.
• Monitors and tracks project progression with effective cross functional stakeholder communication, using established project management processes.
• Reviews and critically appraises scientific literature to provide support and advice to medical and marketing groups in developing strategy and tactical implementation plans.
Data Generation and Publication Planning
• Supports the development of publication plans covering country/regional data generation needs.
• Facilitates and supports investigators, who wish to conduct investigator sponsored, collaborative or Jazz sponsored studies in line with Jazz strategy.
• Supports the approval and implementation of these projects in line with relevant pharmaceutical regulations and Jazz SOPs as appropriate.
• Supports the development and execution of any study plans to provide data to support the portfolio of Jazz Oncology products in phase III-IV, RWE, observational and pharmaco-economic studies.
  
  This is a field-based role and the majority of the work will be externally-facing so will require both national and international travel for both internal and external meetings.
• Clear and concise communication and presentation skills.
• Excellent planning and organisational skills.
• Confident use of IT equipment (with contingency planning), for delivery of F2F in-person and F2F remote interactions.
• Excellent command of English (verbal and written).
• Clear, structured communication and presentation skills.
• Engages actively with company IT systems, reporting tools and collaborative working tools to ensure compliant reporting, excellent record keeping and information sharing.
• Experience with electronic CRM systems.
• Strong interpersonal relationship building skills/collaboration and teamwork.
• Experience in Solid Oncology is essential, HER2 Oncology knowledge is strongly preferred.
• Experience developing and implementing Medical Affairs plans at a country level.
• Experience of working in a pharmaceutical company affiliate Medical Affairs role a distinct advantage.
• Experience in establishing strong influential relationships with academic societies and patient organisations.
Required Education and Licenses
• Qualification as a Pharmacist or Medical Doctor essential
• Proven experience as an ABPI asset reviewer and Final signatory
  
  Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines and novel product candidates, from early- to late-stage development, in neuroscience and oncology. We actively explore new options for patients including novel compounds, small molecules and biologics, and through cannabinoid science and innovative delivery technologies. Jazz is headquartered in Dublin, Ireland and has employees around the globe, serving patients in nearly 75 countries. For more information, please visit www.jazzpharma.com and follow @JazzPharma on Twitter.